GSK Investigational Site

Richland, Michigan 49083

0 studies enrolling now · 7 studies all time

What they study most

Acellular Pertussis, Diphtheria, Infections, Bacterial, Infections, Meningococcal, Measles, Migraine Disorders, Mumps, Pulmonary Disease, Chronic Obstructive, Rhinitis, Allergic, Perennial, Rubella, Tetanus, Varicella

Studies at this site

• Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 — Completed
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age — Completed
• Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 — Completed
• Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years — Completed
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents — Completed
• Seasonal Allergic Rhinitis In Pediatric Subjects — Completed